Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
14 pending office actions • 2 art units • 12 examiners • 0 of 14 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Caregen Co., Ltd. has 16 pending office actions focused in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 14 distinct examiners. Interestingly, these 14 examiners are concentrated within only 2 distinct art units, suggesting a very high level of administrative focus for the company's patent filings. This concentration implies that the company's technology falls into very specific categories that are repeatedly reviewed by the same groups.
The busiest examiner for the portfolio is KONOPELSKI SNAVEL, SARA ELIZABETH, who is responsible for 2 pending office actions. With 16 pending office actions and 14 distinct examiners, most examiners are handling a single matter, while a few manage more than one. Practitioners can expect to encounter the same art unit policies across nearly all of the company's 16 active matters. This structure allows for a more unified prosecution strategy within the Biotechnology & Pharmaceuticals sector. The high volume of 16 pending office actions indicates a robust and active patenting program concentrated in a narrow technical field.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (7%) |
| §101 + other | 6 (43%) |
| Multi-statute (no §101) | 7 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KONOPELSKI SNAVEL, SARA ELIZABETH | 2 | 33.3% | +38.9% |
| BEANE, RANDALL L | 2 | 32.8% | +36.8% |
| BRADLEY, CHRISTINA | 1 | 62.6% | +33.3% |
| BANERJEE, KOYELI | 1 | 50.0% | +0.0% |
| COFFA, SERGIO | 1 | 61.1% | +32.5% |
| HA, JULIE | 1 | 75.7% | +44.0% |
| BORGEEST, CHRISTINA M | 1 | 55.6% | +21.4% |
| CARTER, SANDRA DILLAHUNT | 1 | 56.2% | +29.0% |
| JAUHARI, SACHI | 1 | 60.0% | +80.0% |
| HELLMAN, KRISTINA M | 1 | 65.3% | +55.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009452 | COMPOSITION FOR PREVENTION, IMPROVEMENT OR TREATMENT OF ALLERGIC DISEASE OR ITCHING COMPRISING PENTAPEPTIDE AS ACTIVE INGREDIENT | KOMATSU, LI N | 97d overdue |
| 18038607 | PEPTIDE HAVING PROTECTIVE ACTIVITY AGAINST CELL DAMAGE CAUSED BY PARTICULATE MATTER, AND USES FOR SAME | BEANE, RANDALL L | 4d overdue |
| 17629313 | PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF | NIEBAUER, RONALD T | 3d overdue |
| 18850815 | PEPTIDE HAVING ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES AND USE THEREOF | BRADLEY, CHRISTINA | — |
| 18695526 | PEPTIDE HAVING ACTIVITY OF PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH AND USE THEREOF | BANERJEE, KOYELI | — |
| 18724255 | PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF | COFFA, SERGIO | — |
| 18724352 | PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF | KONOPELSKI SNAVEL, SARA ELIZABETH | — |
| 18724295 | PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF | HA, JULIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18038607 | PEPTIDE HAVING PROTECTIVE ACTIVITY AGAINST CELL DAMAGE CAUSED BY PARTICULATE MATTER, AND USES FOR SAME | BEANE, RANDALL L | 4d overdue |
| 18850815 | PEPTIDE HAVING ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES AND USE THEREOF | BRADLEY, CHRISTINA | — |
| 18724255 | PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF | COFFA, SERGIO | — |
| 18724352 | PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF | KONOPELSKI SNAVEL, SARA ELIZABETH | — |
| 18724295 | PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF | HA, JULIE | — |
| 18706717 | PEPTIDE HAVING PHYSIOLOGICAL ACTIVITIES AND USE THEREOF | BORGEEST, CHRISTINA M | — |
| 18706716 | PEPTIDE HAVING PHYSIOLOGICAL ACTIVITY AND USE THEREOF | CARTER, SANDRA DILLAHUNT | — |
| 18697403 | PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF | JAUHARI, SACHI | — |
| Art Unit | Apps |
|---|---|
| 1658 | 3 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18850815 | PEPTIDE HAVING ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES AND USE THEREOF | BRADLEY, CHRISTINA | — | §102§103 | Non-Final OA | — | Pending | Sep 25, 2024 |
| 18695526 | PEPTIDE HAVING ACTIVITY OF PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH AND USE THEREOF | BANERJEE, KOYELI | — | §101§102§112 | Non-Final OA | — | Pending | Aug 30, 2024 |
| 18724255 | PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF | COFFA, SERGIO | 1658 | §102§112 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18724352 | PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF | KONOPELSKI SNAVEL, SARA ELIZABETH | — | §101§112 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18724295 | PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF | HA, JULIE | — | §101 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18706717 | PEPTIDE HAVING PHYSIOLOGICAL ACTIVITIES AND USE THEREOF | BORGEEST, CHRISTINA M | — | §101§102§103§112 | Non-Final OA | — | Pending | May 01, 2024 |
| 18706716 | PEPTIDE HAVING PHYSIOLOGICAL ACTIVITY AND USE THEREOF | CARTER, SANDRA DILLAHUNT | — | §102§112 | Non-Final OA | — | Pending | May 01, 2024 |
| 18697403 | PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF | JAUHARI, SACHI | — | §102§112 | Non-Final OA | — | Pending | Mar 29, 2024 |
| 18697386 | PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF | KONOPELSKI SNAVEL, SARA ELIZABETH | — | §101§102§112 | Non-Final OA | — | Pending | Mar 29, 2024 |
| 18695739 | PEPTIDE HAVING ANTI-INFLAMMATORY ACTIVITY AND USE THEREOF | HELLMAN, KRISTINA M | — | §102§112 | Non-Final OA | — | Pending | Mar 26, 2024 |
| 18695068 | PEPTIDE HAVING ACTIVITY OF PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH, AND USE THEREOF | BEANE, RANDALL L | — | §102§112Other | Non-Final OA | — | Pending | Mar 25, 2024 |
| 18038607 | PEPTIDE HAVING PROTECTIVE ACTIVITY AGAINST CELL DAMAGE CAUSED BY PARTICULATE MATTER, AND USES FOR SAME | BEANE, RANDALL L | 1654 | §101§102§112 | Non-Final OA | 4d overdue | Pending | May 24, 2023 |
| 18009452 | COMPOSITION FOR PREVENTION, IMPROVEMENT OR TREATMENT OF ALLERGIC DISEASE OR ITCHING COMPRISING PENTAPEPTIDE AS ACTIVE INGREDIENT | KOMATSU, LI N | 1658 | §102§103§112Other | Non-Final OA | 97d overdue | Pending | Dec 09, 2022 |
| 17629313 | PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF | NIEBAUER, RONALD T | 1658 | §101§112 | Final Rejection | 3d overdue | Pending | Jan 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial